Leica BOND Ready To Use Primary Antibodies Immunohistochemistry (IHC- Hematologic Disorder and blood cancer marker) - HSA Registration DE0505428
Access comprehensive regulatory information for Leica BOND Ready To Use Primary Antibodies Immunohistochemistry (IHC- Hematologic Disorder and blood cancer marker) in the Singapore medical device market through Pure Global AI's free database. This CLASS B IVD medical device is registered under HSA registration number DE0505428 and owned by Leica Biosystems Newcastle Ltd. The device was registered on February 03, 2021.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
Intended to be used for the qualitative identification by light microscopy of human light chains in formalin-fixed, paraffin-embedded tissue by immunohistochemical staining using the automated BOND system (includes Leica BOND-MAX system and Leica BOND-III system).